2012;5(4):395-407. AML: Acute myeloid leukemia; APL: Acute promyelocytic leukemia; CBF: Core-binding factor; CEBPA-DM: CCAAT enhancer-binding protein-α with double mutation; CN-AML ...

Invivoscribe, a global leader in precision diagnostics, is pleased to announce the successful listings of the LeukoStrat CDx FLT3 Mutation Assay in both the United Kingdom (UK) and Switzerland. The ...

SAN DIEGO, March 27, 2025--(BUSINESS WIRE)--Invivoscribe, a global leader in precision diagnostics, is pleased to announce the successful listings of the LeukoStrat CDx FLT3 Mutation Assay in both ...

The LeukoStrat CDx FLT3 Mutation ... AML for whom VANFLYTA (quizartinib hydrochloride) treatment is being considered. The qualitative, non-automated test is for use on the 3500xL or 3500xL Dx ...

Invivoscribe, a global leader in precision diagnostics, is pleased to announce the successful listings of the LeukoStrat CDx FLT3 Mutation Assay ... myeloid leukemia (AML). Regulatory compliance ...